The World Health Organization (WHO) has approved the first-ever diagnostic test for the Ebola Bundibugyo virus, adding it to its Emergency Use Listing (EUL). The move marks a major step in strengthening the global response to the ongoing Ebola outbreak in Central Africa.

Announced on July 2, the emergency listing allows countries and international agencies to procure and deploy the Ebola Bundibugyo test more rapidly during public health emergencies. The test detects the virus by identifying its genetic material in blood samples, enabling faster and more accurate laboratory confirmation of infection.

Why This Diagnostic Test Matters

According to WHO, early diagnosis of Ebola Bundibugyo is critical for timely patient care, effective contact tracing, disease surveillance, and outbreak control. The Emergency Use Listing process evaluates the quality, safety, and performance of essential health products while accelerating access, particularly in low- and middle-income countries.

The approval comes amid the ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo, with cases also reported in Uganda. WHO declared the outbreak a Public Health Emergency of International Concern (PHEIC) on May 17, 2026, citing the risk of cross-border spread and the absence of licensed vaccines or targeted treatments for this Ebola strain. WHO has also issued new clinical guidelines for managing Ebola and Marburg cases.

What Happens Next

WHO says the new listing will improve outbreak response by enabling quicker case confirmation, supporting healthcare workers in making faster clinical decisions, and strengthening surveillance efforts. The organization is also working with diagnostic manufacturers to expand access to reliable testing tools for Ebola Bundibugyo.

The development is seen as a key milestone in global health security as international partners intensify efforts to contain the outbreak through improved diagnostics, surveillance, research, and clinical trials.